APA (7th ed.) Citation

Hellgren, J., Compagno Strandberg, M., Hansson, O., Janelidze, S., Källén, K., Svenningsson, A., & Fee, D. B. (2026). Association Between Fatigue, Information Processing Speed and Plasma Levels of Glial Fibrillary Acidic Protein and Neurofilament Light in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Natalizumab or Rituximab. Acta Neurologica Scandinavica, 2026, 1. https://doi.org/10.1155/ane/5453262

Chicago Style (17th ed.) Citation

Hellgren, Johan, Maria Compagno Strandberg, Oskar Hansson, Shorena Janelidze, Kristina Källén, Anders Svenningsson, and Dominic B. Fee. "Association Between Fatigue, Information Processing Speed and Plasma Levels of Glial Fibrillary Acidic Protein and Neurofilament Light in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Natalizumab or Rituximab." Acta Neurologica Scandinavica 2026 (2026): 1. https://doi.org/10.1155/ane/5453262.

MLA (9th ed.) Citation

Hellgren, Johan, et al. "Association Between Fatigue, Information Processing Speed and Plasma Levels of Glial Fibrillary Acidic Protein and Neurofilament Light in Patients With Relapsing–Remitting Multiple Sclerosis Treated With Natalizumab or Rituximab." Acta Neurologica Scandinavica, vol. 2026, 2026, p. 1, https://doi.org/10.1155/ane/5453262.